Zobrazeno 1 - 10
of 50
pro vyhledávání: '"Caterina Marchiò"'
Autor:
Eleonora Pagan, Richard D. Gelber, Fabio Conforti, Christos Sotiriou, Silvana Pileggi, Anna Sapino, Caterina Marchiò, Philippe Aftimos, Rossella Graffeo, Chiara Pesenti, Laetitia Collet, Giulia Peruzzotti, Vincenzo Bagnardi, Giovanni Corso, Marco Colleoni, Tommaso De Pas, Giuseppe Viale, Laura Pala, Martine Piccart, Caterina Fumagalli, Elena Guerini Rocco, Emilia Montagna, Sergio Marchini, Aron Goldhirsch
Publikováno v:
The Breast : Official Journal of the European Society of Mastology
Breast, 59
Breast, Vol 59, Iss, Pp 94-101 (2021)
Breast, 59
Breast, Vol 59, Iss, Pp 94-101 (2021)
Background We report here for the first time, a comprehensive characterization of biological and clinical features of early-stage triple negative Invasive Lobular Carcinomas(TN-ILCs) Methods We analyzed all consecutive patients with early-stage TN-IL
Autor:
Daniel Moya-Rull, Annunziata Gloghini, Andrea Sartore-Bianchi, Salvatore Siena, Ivana Sarotto, Simonetta Guarrera, Sara Erika Bellomo, Stefania Manenti, Emanuele Rausa, Laura D'Errico, Ida Rapa, Sabrina Rizzolio, Uberto Fumagalli, Rossella Reddavid, Claudia Castelli, Caterina Marchiò, Carla Baronchelli, Tania Capeloa, Federica Morano, Simona Corso, Michele Sacco, Dario Ribero, Stefano De Pascale, Gian Luca Baiocchi, Federica Tosi, Maria Apicella, Salvatore Ribisi, Paola Cassoni, Maurizio Degiuli, Sarah Molfino, Giovanni Sgroi, Silvia Marsoni, Michele Prisciandaro, Stefania Durando, Cristina Migliore, Annalisa Petrelli, Antonino Sottile, Filippo Pietrantonio, Silvia Giordano, Alessandra Raimondi, Anna Sapino, Maria Bencivenga, Stefano Ughetto
Publikováno v:
Gastric Cancer. 24:897-912
Trastuzumab is the only approved targeted therapy in patients with HER2-amplified metastatic gastric cancer (GC). Regrettably, in clinical practice, only a fraction of them achieves long-term benefit from trastuzumab-based upfront strategy. To advanc
Autor:
Lounes Djerroudi, Matthias Christgen, Patrick W. B. Derksen, Anne Vincent-Salomon, Hans Kreipe, Gábor Cserni, Caterina Marchiò, Giuseppe Floris
Publikováno v:
Cancers
Cancers, Vol 13, Iss 3695, p 3695 (2021)
Cancers, Vol 13, Iss 3695, p 3695 (2021)
Simple Summary Invasive lobular breast cancer (ILC) is a special type of breast cancer (BC) that was first described in 1941. The diagnosis of ILC is made by microscopy of tumor specimens, which reveals a distinct morphology. This review recapitulate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e5f0e67e402e9d6b817d2f4cf74f2373
https://lirias.kuleuven.be/handle/20.500.12942/703139
https://lirias.kuleuven.be/handle/20.500.12942/703139
Autor:
Islam M. Miligy, Rebecca Millican-Slater, Emad A. Rakha, Andrew H S Lee, Cecily Quinn, Colin A. Purdie, Dave Purnell, Karim Eldib, Janice M. Walshe, Ciara Murray, Michael S. Toss, Ayaka Katayama, Caterina Marchiò, Elena Provenzano, Ian O. Ellis, Bruce Tanchel, Grace Gallagy, Sarah E Pinder, Nahla Badr, Abeer M Shaaban
Publikováno v:
British Journal of Cancer
Background The ASCO/CAP guidance on HER2 testing in breast cancer (BC) has recently changed. Group 2 tumours with immunohistochemistry score 2+ and HER2/CEP17 ratio ≥2.0 and HER2 copy number Methods 749 BC cases were identified from 11 institutions
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::74b0da954d72ed70689483771514ebe2
https://www.repository.cam.ac.uk/handle/1810/322963
https://www.repository.cam.ac.uk/handle/1810/322963
Autor:
Caterina Marchiò, Felipe C Geyer, Edi Brogi, David R. Brown, Jorge S. Reis-Filho, Britta Weigelt, Fresia Pareja, A Da Cruz Paula, Jy Lee, A Vincent-Salomon, Pier Selenica
Publikováno v:
Cancer Research. 79:P3-06
Introduction: Mucinous (MBCs) and neuroendocrine breast carcinomas (NBCs) are special histologic types of estrogen receptor (ER)-positive breast cancers. Together, MBCs and NBCs account for approximately 5% of invasive breast cancers. NBCs are define
Autor:
Francois Richard, M.J. Piccart, G Rouas, D. Larsimont, Diether Lambrechts, David R. Brown, Giancarlo Pruneri, Florian Clatot, S Majjaj, Bram Boeckx, C Desmedt, G. Van den Eynden, Caterina Marchiò, Françoise Rothé, Anne Vincent-Salomon, Odette Mariani, Christos Sotiriou, Christine Galant, Julien Pingitore, François Bertucci, Roberto Salgado
Publikováno v:
Cancer Research. 79:GS1-06
Background: Invasive lobular breast cancer (ILC) represents the second most common histology of breast cancer, accounts for 10-15% of all invasive cases and generally expresses the estrogen receptor (ER, coded by the ESR1 gene). Little is known about
Autor:
Mattia Garutti, Gaia Griguolo, Andrea Botticelli, Giulia Buzzatti, Carmine De Angelis, Lorenzo Gerratana, Chiara Molinelli, Vincenzo Adamo, Giampaolo Bianchini, Laura Biganzoli, Giuseppe Curigliano, Michelino De Laurentiis, Alessandra Fabi, Antonio Frassoldati, Alessandra Gennari, Caterina Marchiò, Francesco Perrone, Giuseppe Viale, Claudio Zamagni, Alberto Zambelli, Lucia Del Mastro, Sabino De Placido, Valentina Guarneri, Paolo Marchetti, Fabio Puglisi
Publikováno v:
Cancers. 14:1898
Breast cancer is one of the major causes of cancer-related morbidity and mortality in women worldwide. During the past three decades, several improvements in the adjuvant treatment of hormone receptor-positive/HER2−negative breast cancer have been
Autor:
Elisabetta Marangoni, Elodie Manié, Nadège Gruel, Gaëtan MacGrogan, Ivan Bièche, Laetitia Fuhrmann, Cécile Laurent, Dominique Stoppa-Lyonnet, Marc-Henri Stern, Roman Rouzier, Caterina Marchiò, Jaydutt Bhalshankar, Pierre Romero, Sophie Vacher, Gabrielle Deniziaut, Fabien Reyal, Frédérique Berger, Tatiana Popova, Anne Vincent-Salomon, Vanessa Benhamo, Olivier Delattre
Publikováno v:
The American Journal of Pathology. 188:2378-2391
Medullary breast carcinoma (MBC) is a rare subtype of triple-negative breast cancer with specific genomic features within the spectrum of basal-like carcinoma (BLC). In this study of 19 MBCs and 36 non-MBC BLCs, we refined the transcriptomic and geno
Publikováno v:
Pathologica
Summary Atypical ductal hyperplasia (ADH), atypical lobular hyperplasia (ALH) and flat epithelial atypia (FEA) are common lesions mainly detected during mammographic screening. They are considered lesions at risk for the development of breast cancer,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5826e0fd819c013490ce62eda2350cd1
http://hdl.handle.net/2318/1861199
http://hdl.handle.net/2318/1861199
Autor:
Nicola Fusco, Umberto Malapelle, Matteo Fassan, Caterina Marchiò, Simonetta Buglioni, Simonetta Zupo, Carmen Criscitiello, Paolo Vigneri, Angelo Paolo Dei Tos, Eugenio Maiorano, Giuseppe Viale
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology
Frontiers in Oncology
Despite the significant achievements in the diagnosis and treatment of metastatic breast cancer (MBC), this condition remains substantially an incurable disease. In recent years, several clinical studies have aimed to identify novel molecular targets
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::db98d0d98a36c47511f4dcc96576708e
https://hdl.handle.net/20.500.11769/548852
https://hdl.handle.net/20.500.11769/548852